English | Español

Amgen Inc.
Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients
Erianne Leatherman | Apr 9, 2017

Amgen’s BLINCYTO to receive priority review from FDA
Erianne Leatherman | Apr 7, 2017

Repatha shows no memory effects while lowering LDL levels, study finds
Robert Hadley | Mar 28, 2017

European Commission approves Amgen's new anti-inflammatory drug
Robert Hadley | Mar 22, 2017

Amgen’s Repatha may help patients with tough cases of high cholesterol
Robert Hadley | Mar 17, 2017

Clinical trial shows immunotherapy can extend leukemia patients' life expectancy
Mark Iandolo | Oct 24, 2016

Amgen announces study regarding its XGEVA product
Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments

Trending
+ Regulatory
C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'